Advertisement
Advertisement
Trending on Psychiatric Times
1
New Phase 3 Data on Oveporexton for Narcolepsy Type 1
2
Glyph Allopregnanolone for Major Depressive Disorder Meets Phase 1 Endpoints
3
The Instincts Behind a Career in Treatment-Resistant Depression: A Conversation With Maurizio Fava, MD
4
NIH Awards Grant to Jonathan Purtle, DrPH, to Study Experiences Using 988
5